Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-03-29
DOI
10.3389/fphar.2019.00285
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alteronol induces cell cycle arrest and apoptosis via increased reactive oxygen species production in human breast cancer T47D cells
- (2018) Boxue Ren et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- The co‑treatment of metformin with flavone synergistically induces apoptosis through inhibition of PI3K/AKT pathway in breast cancer cells
- (2018) Zhaodi Zheng et al. Oncology Letters
- Detergent sclerosants at sub-lytic concentrations induce endothelial cell apoptosis through a caspase dependent pathway
- (2016) Osvaldo Cooley-Andrade et al. APOPTOSIS
- A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways
- (2016) Jun-Yu Ke et al. TUMOR BIOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Synergistic cytotoxicity from combination of imatinib and platinum-based anticancer drugs specifically in Bcr-Abl positive leukemia cells
- (2015) Yuming Wei et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells
- (2015) Jin Mo Ku et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- In vivo anticancer synergy mechanism of doxorubicin and verapamil combination treatment is impaired in BALB/c mice with metastatic breast cancer
- (2014) Michelle McCarthy et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells
- (2014) LIN ZHAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Alteronol inhibits the invasion and metastasis of B16F10 and B16F1 melanoma cells in vitro and in vivo
- (2014) Zhenhua Wang et al. LIFE SCIENCES
- Oxidative stress-induced cyclin D1 depletion and its role in cell cycle processing
- (2013) Chul-Woong Pyo et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Liposomal temocene (m-THPPo) photodynamic treatment induces cell death by mitochondria-independent apoptosis
- (2013) Jorge Soriano et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- A new jasmonic acid stereoisomeric derivative induces apoptosis via reactive oxygen species in human prostate cancer cells
- (2012) Alessandra Russo et al. CANCER LETTERS
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
- Alteronol inhibits proliferation in HeLa cells through inducing a G1-phase arrest
- (2011) Ying Yao et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Alternol exerts prostate-selective antitumor effects through modulations of the AMPK signaling pathway
- (2011) Eddie D. Yeung et al. PROSTATE
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Reactive oxygen species, cellular redox systems, and apoptosis
- (2010) Magdalena L. Circu et al. FREE RADICAL BIOLOGY AND MEDICINE
- β-cyclodextrin-centered star-shaped amphiphilic polymers for doxorubicin delivery
- (2010) Li Yan Qiu et al. Nanomedicine
- MAP kinase and pain
- (2008) Ru-Rong Ji et al. BRAIN RESEARCH REVIEWS
- Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action
- (2008) J. Hou et al. CLINICAL CANCER RESEARCH
- Trastuzumab plus Paclitaxel or Docetaxel in HER-2-Negative/HER-2 ECD-Positive Anthracycline- and Taxane-Refractory Advanced Breast Cancer
- (2008) A. Ardavanis et al. ONCOLOGIST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now